Jeffrey D. Bjorge

2.2k total citations
32 papers, 1.9k citations indexed

About

Jeffrey D. Bjorge is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jeffrey D. Bjorge has authored 32 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Jeffrey D. Bjorge's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Protein Tyrosine Phosphatases (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Jeffrey D. Bjorge is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Protein Tyrosine Phosphatases (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Jeffrey D. Bjorge collaborates with scholars based in Canada, Australia and United States. Jeffrey D. Bjorge's co-authors include Donald J. Fujita, Andrew Jakymiw, Jeffrey E. Kudlow, Daishi Fujita, Shudong Zhu, Tung O. Chan, Andrew J. Paterson, Heung‐Chin Cheng, M Antczak and H J Kung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Jeffrey D. Bjorge

32 papers receiving 1.8k citations

Peers

Jeffrey D. Bjorge
S Nishibe United States
Christopher J. Molloy United States
W. Michael Kavanaugh United States
Bruce D. Cuevas United States
E. Y. Skolnik United States
Michael D. Waterfield United Kingdom
Joseph Schlessinger United States
Linda S. Mulcahy United States
S Nishibe United States
Jeffrey D. Bjorge
Citations per year, relative to Jeffrey D. Bjorge Jeffrey D. Bjorge (= 1×) peers S Nishibe

Countries citing papers authored by Jeffrey D. Bjorge

Since Specialization
Citations

This map shows the geographic impact of Jeffrey D. Bjorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Bjorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Bjorge more than expected).

Fields of papers citing papers by Jeffrey D. Bjorge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey D. Bjorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Bjorge. The network helps show where Jeffrey D. Bjorge may publish in the future.

Co-authorship network of co-authors of Jeffrey D. Bjorge

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Bjorge. A scholar is included among the top collaborators of Jeffrey D. Bjorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Bjorge. Jeffrey D. Bjorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bjorge, Jeffrey D., et al.. (2014). EGFR and HER2 levels are frequently elevated in colon cancer cells. 1(1). e1–e1. 23 indexed citations
3.
Yu, Lisa, Satbir Thakur, Asuka Suzuki, et al.. (2013). Src Regulates the Activity of the ING1 Tumor Suppressor. PLoS ONE. 8(4). e60943–e60943. 20 indexed citations
4.
Hossain, Mohammed Iqbal, Carli L. Roulston, Dominic C.H. Ng, et al.. (2013). A Truncated Fragment of Src Protein Kinase Generated by Calpain-mediated Cleavage Is a Mediator of Neuronal Death in Excitotoxicity. Journal of Biological Chemistry. 288(14). 9696–9709. 37 indexed citations
5.
Zhu, Shudong, et al.. (2013). PI3K inhibition potentiates Bcl‐2‐dependent apoptosis in renal carcinoma cells. Journal of Cellular and Molecular Medicine. 17(3). 377–385. 12 indexed citations
6.
Zhu, Shudong, Jeffrey D. Bjorge, & Donald J. Fujita. (2011). Src is dephosphorylated at tyrosine 530 in human colon carcinomas. Chinese Journal of Cancer Research. 23(3). 229–231. 5 indexed citations
8.
Bjorge, Jeffrey D., et al.. (2010). The von Hippel-Lindau Tumor Suppressor Protein Is Destabilized by Src: Implications for Tumor Angiogenesis and Progression. Genes & Cancer. 1(3). 225–238. 31 indexed citations
9.
Zhu, Shengze, Jeffrey D. Bjorge, Heung‐Chin Cheng, & Daishi Fujita. (2007). Decreased CHK protein levels are associated with Src activation in colon cancer cells. Oncogene. 27(14). 2027–2034. 19 indexed citations
10.
Chong, Yuh‐Ping, Nicholas A. Williamson, Edwina C. Lerner, et al.. (2006). C-terminal Src Kinase-homologous Kinase (CHK), a Unique Inhibitor Inactivating Multiple Active Conformations of Src Family Tyrosine Kinases. Journal of Biological Chemistry. 281(44). 32988–32999. 34 indexed citations
11.
Chong, Yuh‐Ping, Terrence D. Mulhern, Hong‐Jian Zhu, et al.. (2004). A Novel Non-catalytic Mechanism Employed by the C-terminal Src-homologous Kinase to Inhibit Src-family Kinase Activity. Journal of Biological Chemistry. 279(20). 20752–20766. 47 indexed citations
12.
Bjorge, Jeffrey D., Andrew Jakymiw, & Donald J. Fujita. (2000). Selected glimpses into the activation and function of Src kinase. Oncogene. 19(49). 5620–5635. 347 indexed citations
14.
Hibbs, Margaret L., Paul Bello, Jeffrey D. Bjorge, et al.. (1998). Common in Vitro Substrate Specificity and Differential Src Homology 2 Domain Accessibility Displayed by Two Members of the Src Family of Protein-tyrosine Kinases, c-Src and Hck. Journal of Biological Chemistry. 273(27). 16756–16763. 13 indexed citations
15.
Johnson, Timothy M., John W. Perich, Jeffrey D. Bjorge, Donald J. Fujita, & Heung‐Chin Cheng. (1997). Common and differential recognition of structural features in synthetic peptides by the catalytic domain and the Src‐Homology 2 (SH2) domain of pp60c‐src. Journal of Peptide Research. 50(5). 365–371. 15 indexed citations
16.
Bjorge, Jeffrey D., et al.. (1997). Tyrosine Phosphorylation of Annexin II Tetramer Is Stimulated by Membrane Binding. Journal of Biological Chemistry. 272(6). 3195–3199. 35 indexed citations
17.
Bjorge, Jeffrey D., et al.. (1996). Activation of human pp60c-src. Biochemistry and Cell Biology. 74(4). 477–484. 19 indexed citations
18.
Bjorge, Jeffrey D., et al.. (1995). Characterization of Two Activated Mutants of Human pp60c- That Escape c-Src Kinase Regulation by Distinct Mechanisms. Journal of Biological Chemistry. 270(41). 24222–24228. 51 indexed citations
19.
Bjorge, Jeffrey D., et al.. (1995). Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry. 34(44). 14527–14534. 71 indexed citations
20.
Bjorge, Jeffrey D., Jeffrey E. Kudlow, G B Mills, & Andrew J. Paterson. (1989). Inhibition of stimulus‐dependent epidermal growth factor receptor and transforming growth factor‐α mRNA accumulation by the protein kinase C inhibitor staurosporine. FEBS Letters. 243(2). 404–408. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026